‘Sec. 1. 17-A MRSA §1101, sub-§24, as enacted by PL 2015, c. 346, §3, is amended to read:
24. "Fentanyl powder" means any compound, mixture or preparation, in granular or powder form, containing fentanyl or any derivative of fentanyl listed in section 1102, subsection 1, paragraph I in any quantity.
Sec. 2. 17-A MRSA §1102, sub-§1, ¶I, as amended by PL 2015, c. 492, §1, is further amended to read:
I. Unless listed or described in another schedule, any compound, mixture or preparation containing narcotic drugs in any quantity, including, but not limited to, the following narcotic drugs or their salts, isomers or salts of isomers: heroin (diacetylmorphine) , ; methadone , ; methadone hydrochloride , ; levo-alpha-acetyl-methadol, or LAAM , ; pethidine , ; opium; morphine , ; oxycodone , ; hydrocodone , ; hydromorphone , ; buprenorphine , ; U-47700; W-18; W-15; AH-7921; carfentanil; sufentanil; fentanyl powder; and any derivative of fentanyl powder by any substitution on or replacement of the phenethyl group, any substitution on the piperidine ring, any substitution on or replacement of the propanamide group, any substitution on the phenyl group or any combination thereof, including, but not limited to, despropionyl fentanyl, furanylfentanyl, fluorofentanyl, 4-fluoroisobutyryl fentanyl, acetylfentanyl and any methylfentanyl derivatives and opium;’